236 related articles for article (PubMed ID: 9698123)
1. Positive diagnostic values and histological detection ratios from the Rotterdam cervical cancer screening programme.
Kreuger FA; Beerman H; Nijs HG; van Ballegooijen M
Int J Epidemiol; 1998 Jun; 27(3):377-81. PubMed ID: 9698123
[TBL] [Abstract][Full Text] [Related]
2. High-risk HPV testing in women with borderline and mild dyskaryosis: long-term follow-up data and clinical relevance.
Denise Zielinski G; Snijders PJ; Rozendaal L; Voorhorst FJ; Runsink AP; de Schipper FA; Meijer CJ
J Pathol; 2001 Oct; 195(3):300-6. PubMed ID: 11673826
[TBL] [Abstract][Full Text] [Related]
3. Determination of the diagnostic accuracy of testing for high-risk (HR) human papillomavirus (HPV) types 16, 18 and 45 in precancerous cervical lesions: preliminary data.
Tiews S; Steinberg W; Schneider W; Hanrath C
J Clin Virol; 2009 Nov; 46 Suppl 3():S11-5. PubMed ID: 20129068
[TBL] [Abstract][Full Text] [Related]
4. The borderline cervical smear: colposcopic and biopsy outcome.
al-Nafussi A; Rebello G; al-Yusif R; McGoogan E
J Clin Pathol; 2000 Jun; 53(6):439-44. PubMed ID: 10911801
[TBL] [Abstract][Full Text] [Related]
5. Relation of human papillomavirus status to cervical lesions and consequences for cervical-cancer screening: a prospective study.
Nobbenhuis MA; Walboomers JM; Helmerhorst TJ; Rozendaal L; Remmink AJ; Risse EK; van der Linden HC; Voorhorst FJ; Kenemans P; Meijer CJ
Lancet; 1999 Jul; 354(9172):20-5. PubMed ID: 10406360
[TBL] [Abstract][Full Text] [Related]
6. [The diagnostic value of cytology and colposcopy in women with cervical intraepithelial neoplasia].
Wojciech R
Ginekol Pol; 2011 Aug; 82(8):607-11. PubMed ID: 21957606
[TBL] [Abstract][Full Text] [Related]
7. Cytology versus HPV testing for cervical cancer screening in the general population.
Koliopoulos G; Nyaga VN; Santesso N; Bryant A; Martin-Hirsch PP; Mustafa RA; Schünemann H; Paraskevaidis E; Arbyn M
Cochrane Database Syst Rev; 2017 Aug; 8(8):CD008587. PubMed ID: 28796882
[TBL] [Abstract][Full Text] [Related]
8. Visual inspection of the uterine cervix after the application of acetic acid in the detection of cervical carcinoma and its precursors.
Sankaranarayanan R; Wesley R; Somanathan T; Dhakad N; Shyamalakumary B; Amma NS; Parkin DM; Nair MK
Cancer; 1998 Nov; 83(10):2150-6. PubMed ID: 9827719
[TBL] [Abstract][Full Text] [Related]
9. [Less pap-2 results ('minor abnormalities') in the population screening for cervical cancer since the introduction of new guidelines in 1996].
Bos AB; van Ballegooijen M; van den Akker-van Marle ME; Habbema JD
Ned Tijdschr Geneeskd; 2002 Aug; 146(34):1586-90. PubMed ID: 12224483
[TBL] [Abstract][Full Text] [Related]
10. Screening errors in cervical cytologic screening.
van der Graaf Y; Vooijs GP; Gaillard HL; Go DM
Acta Cytol; 1987; 31(4):434-8. PubMed ID: 3604538
[TBL] [Abstract][Full Text] [Related]
11. [Cytological classifications of vaginal smears. Current concepts of complex cytodiagnosis].
Kasabova M
Akush Ginekol (Sofiia); 1984; 23(4):357-64. PubMed ID: 6385754
[No Abstract] [Full Text] [Related]
12. 'Pap smear' for screening of precancerous conditions of cervix.
Noreen R; Qudussi H
J Ayub Med Coll Abbottabad; 2011; 23(2):41-4. PubMed ID: 24800339
[TBL] [Abstract][Full Text] [Related]
13. Detection, diagnostic evaluation and treatment of dysplasia, carcinoma in situ and early invasive cervical carcinoma.
Nelson JH; Averette HE; Richart RM
CA Cancer J Clin; 1979; 29(3):174-92. PubMed ID: 109174
[No Abstract] [Full Text] [Related]
14. Establishment of a national cervical screening programme in Ireland, CervicalCheck: the first 6 years.
Flannelly GM; Mooney MT; Greehy GM; Keogh EB; McNally SA; Fitzpatrick PE
Eur J Cancer Prev; 2018 Mar; 27(2):158-163. PubMed ID: 27824660
[TBL] [Abstract][Full Text] [Related]
15. False-negative Papanicolaou smears from women with cancerous and precancerous lesions of the uterine cervix.
Pairwuti S
Acta Cytol; 1991; 35(1):40-6. PubMed ID: 1994633
[TBL] [Abstract][Full Text] [Related]
16. Smear biopsies: a cause of negative follow-up biopsies in patients with premalignant conditions of the uterine cervix.
Berner A; Høeg K; Oppedal BR
Diagn Gynecol Obstet; 1980; 2(2):99-101. PubMed ID: 7439010
[TBL] [Abstract][Full Text] [Related]
17. Monitoring and evaluation of a model demonstration project for the control of cervical cancer in Nakhon Phanom province, Thailand.
Deerasamee S; Srivatanakul P; Sriplung H; Nilvachararung S; Tansuwan U; Pitakpraiwan P; Kaewkungwal J; Singhasivanon P; Nimnakorn P; Sankaranarayanan R
Asian Pac J Cancer Prev; 2007; 8(4):547-56. PubMed ID: 18260727
[TBL] [Abstract][Full Text] [Related]
18. Immediate referral to colposcopy versus cytological surveillance for minor cervical cytological abnormalities in the absence of HPV test.
Kyrgiou M; Kalliala IE; Mitra A; Fotopoulou C; Ghaem-Maghami S; Martin-Hirsch PP; Cruickshank M; Arbyn M; Paraskevaidis E
Cochrane Database Syst Rev; 2017 Jan; 1(1):CD009836. PubMed ID: 28125861
[TBL] [Abstract][Full Text] [Related]
19. Risk-adapted primary HPV cervical cancer screening project in Wolfsburg, Germany--experience over 3 years.
Luyten A; Scherbring S; Reinecke-Lüthge A; Braun BE; Pietralla M; Theiler K; Petry KU
J Clin Virol; 2009 Nov; 46 Suppl 3():S5-10. PubMed ID: 20129072
[TBL] [Abstract][Full Text] [Related]
20. Prediction of cervical intraepithelial neoplasia grade 2-3 using risk assessment and human papillomavirus testing in women with atypia on papanicolaou smears.
Shlay JC; Dunn T; Byers T; Barón AE; Douglas JM
Obstet Gynecol; 2000 Sep; 96(3):410-6. PubMed ID: 10960635
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
